Assessment of Coeliac Disease in Patients With Type 2 Diabetes
This study aims to screen and diagnose coeliac disease in patients with type 2 diabetes and monitor the effect of gluten-free diet on the metabolic status
- EligibilityCriteria: Inclusion Criteria:  adult patients ≥18 years old diagnosed with type 2 diabetes mellitus  Exclusion Criteria:  Patients already diagnosed with co-morbid autoimmune disorder patient diagnosed as systemic lupus diagnosed as rheumatoid arthritis already diagnosed with coeliac disease - Gender: All - MinimumAge: 18 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult - StudyPopulation: All Diabetic type 2 willing participants, after obtaining informed consent, will be subjected to full history taking, thorough clinical examination and total immunoglobulin A (IgA) and IgA tissue transglutaminase antibody (tTG-Ab). -Those with IgA deficiency or positive tTG-Ab are offered upper endoscopy for confirmation by duodenal biopsy. -Those with confirmed Coeliac Disease will be given detailed dietary advice and promoted to strictly adhere to gluten-free diet - SamplingMethod: Non-Probability Sample